Rentokil appoints shareholder Trian Fund's executive to board
Sept 25 (Reuters) -Rentokil Initial RTO.L on Wednesday appointed Brian Baldwin, the head of research at shareholder Trian Fund Management, to its board months after the Nelson Peltz fund amassed a significant stake in the British pest-control firm.
WHY IT'S IMPORTANT
Rentokil and rival Rollins ROL.N account for roughly half of the U.S. pest control market, with Rentokil the larger player following the Terminix acquisition in 2021.
CONTEXT
The New York-based hedge fund led by activist investor Peltz, holds about 2.6% stake in Rentokil, making it the thirteenth largest shareholder, according to LSEG data.
Peltz is known for his attempts to shake up big firms via Trian Fund, which in June said was interested in discussing "ideas and initiatives" with Rentokil.
The pest-control firm has issued several profit warnings this past year due to weak demand in its largest market, North America. The company has been struggling to integrate its business after acquiring U.S. rival Terminix and flagged a modest disruption to organic growth from the deal in July and August.
KEY QUOTES
"We look forward to working with him (Baldwin) to ... execute our plans to integrate the Terminix business and to increase organic growth in our North America operations," said Richard Solomons, chairman of Rentokil.
MARKET REACTION
Rentokil's shares were up 3.1% at 371.8 pence apiece by 0735 GMT.
Reporting by Prerna Bedi in Bengaluru; Editing by Eileen Soreng
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
